发明名称 |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
摘要 |
A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative and a disintegrating agent is herein disclosed and described. The dosage formulation exhibits a significant increase in bioavailability of the thiazolidinedione derivative component compared to conventional immediate release dosage forms containing only a thiazolidinedione derivative. |
申请公布号 |
US8084058(B2) |
申请公布日期 |
2011.12.27 |
申请号 |
US20050094493 |
申请日期 |
2005.03.30 |
申请人 |
LODIN UNCHALEE;CARDINAL JACK;NANGIA AVINASH;WATSON PHARMACEUTICALS, INC.;TAKEDA PHARMACEUTICAL, CO. LTD. |
发明人 |
LODIN UNCHALEE;CARDINAL JACK;NANGIA AVINASH |
分类号 |
A61K9/24;A61K9/00;A61K9/20;A61K9/22;A61K9/26;A61K9/28;A61K31/155;A61K31/425;A61K31/426;A61K45/06 |
主分类号 |
A61K9/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|